Mostrando 2 resultados de: 2
Cyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase/extracellular signal–regulated kinase pathway activation
ArticleAbstract: Activating mutations in the mitogen-activated protein kinase/extracellular signal–regulated kinase (Palabras claves:BCL-2, Cyclin D1, Ki-67, MAPK/ERK, p-ERK, pathogenesis, Rosai-dorfman diseaseAutores:Bhattacharjee M.B., Coelho Siqueira S.A., Cuglievan B., Garces J.C., Jelloul F.Z., Khoury J.D., Li S., Marques-Piubelli M.L., Medeiros L.J., Medina A.M., Miranda R.N., Saluja K., Sofía A. Garcés, Sriganeshan V., Thakral B., Xu J., Yin C.C.Fuentes:scopusMutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease
ArticleAbstract: Rosai-Dorfman disease is a histiocytic disorder with a poorly defined pathogenesis. Recent molecularPalabras claves:Autores:Garces J.C., Khoury J.D., Li J., Li S., Medeiros L.J., Patel K.P., Pina-Oviedo S., Sofía A. Garcés, Yin C.C.Fuentes:scopus